The CEO's sale is particularly meaningful — traders should monitor for any upcoming earnings releases, clinical trial updates, or regulatory decisions that may have prompted this activity. Consider this a cautionary signal ahead of potential negative news.
Price Chart
Executive Summary
Two corporate insiders at Crinetics Pharmaceuticals sold shares in the past week, including CEO Richard Scott Struthers who sold $489,704 worth of stock. The total value of open-market sales was approximately $651,234, representing a modest but notable insider selling cluster.
Key Financial Metrics
Key Facts
- CEO Richard Scott Struthers sold 13,196 shares at $37.11, totaling $489,704 in open-market transaction.
- Director Rogerio Vivaldi Coelho sold 4,477 shares at $36.08, totaling $161,530 in open-market transaction.
- Total open-market sales by insiders in the past 7 days: $651,234.
- All transactions were open-market sales (Form 4 codes: S), indicating deliberate divestment.
- Combined sales represent ~0.016% of the company's $4.0B market cap.
Financial Impact
$651,234 in total open-market share sales by insiders
Risk Factors
- Insider selling, especially by the CEO, may signal lack of confidence in near-term prospects.
- Potential for negative sentiment pressure on the stock ahead of key catalysts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-CRNX-1773867957958 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 15-12G | — | awaiting T+1 | — | — |
Sep 1, 2026 4w ago | 25-NSE | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Sep 1, 2026 4w ago | 8-K | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Aug 14, 2026 7w ago | 8-K | $84.70 $84.75 | ▲ +0.06% | ▲ +0.53% | — |
Aug 3, 2026 8w ago | Press Release | $83.86 $84.00 | ▲ +0.17% | ▲ +0.37% | — |
Jul 10, 2026 12w ago | DEFA14A | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jul 10, 2026 12w ago | 8-K | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jun 30, 2026 13w ago | Press Release | $38.68 $42.23 | ▲ +9.18% | ▲ +9.31% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access